Denna sida på svenska
Loading profile information...

Research description

Atherosclerosis and its main clinical manifestations, myocardial infarction and stroke, are the leading cause of death worldwide. The overall goal of my research is to identify new cholesterol-responsive drug targets that can reduce atherosclerosis plaque burden, and to identify markers of early atherosclerosis development to define those who could benefit from early treatments. To this end we use mouse models of human-like atherosclerosis together with well-characterized cardiovascular cohorts with genotype, gene-, and protein expression data.  

Loading publication list...